Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-20 07:11 CEST (UTC+2h)

Calculation of Group effect for FDA studies [RSABE / ABEL]

posted by GM - India, 2017-06-09 08:10  - Posting: # 17473
Views: 1,790

Dear All,

What are necessary terms need to be used in ANOVA model, when the study conducted in cohorts (more than one group)...?

Every time I got confused with this.

Kindly suggest, any guidance is available.

Thanks in advance,
GM

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,395 posts in 3,909 threads, 1,174 registered users;
online 34 (0 registered, 34 guests [including 15 identified bots]).

The analysis of variance is not a mathematical theorem,
but rather a convenient method of arranging the arithmetic.    R.A. Fisher

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed